HIT Consultant June 19, 2024
What You Should Know:
– Boston Scientific Corporation (NYSE: BSX) announced a definitive agreement to acquire Silk Road Medical, Inc. (Nasdaq: SILK) for approximately $1.16 billion ($27.50 per share). Silk Road Medical is a leading innovator in minimally invasive stroke prevention technologies for patients with carotid artery disease.
– The acquisition strengthens Boston Scientific’s position in the vascular medicine field, offering physicians a broader range of solutions for treating peripheral vascular disease and improving patient outcomes.
Combating Stroke Risk with TCAR
Carotid artery disease, a narrowing or blockage of the carotid arteries in the neck due to plaque buildup, is a major risk factor for stroke. It’s responsible for roughly one-third of all strokes. Current treatment options include medication,...
Today's Sponsors
Today's Sponsor